When It Got to a Feeding Tube: Severe GLP-1 Stomach Injury

Marin & MurphySuper Lawyers® 2014–2024(888) 348-2735

Ozempic (GLP-1) Lawsuit — Free Case Review

Your Stomach Symptoms Were Real

If you took brand-name Ozempic, Wegovy, or Rybelsus and were diagnosed with a tested, documented stomach injury with an ER or hospital visit, you may qualify.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.

Did this happen to you — or someone you love?

Start your free case reviewTell us anyway

Answered 24/7 · Free & confidential · No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney's fee is a percentage of the gross recovery, calculated before expenses are deducted.

(888) 348-2735

Partners

Matthew T. Marin & Stefanie A. Murphy

Super Lawyers® honorees · American Association for Justice members

Ozempic inquiries get a personal review — and an honest answer either way, free and without obligation.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state. Do not stop, start, or change any prescribed medication because of anything on this page. Those decisions belong with your prescriber. Attorney Advertising.

A small number of people with GLP-1-associated stomach injuries reach the point where eating normally is no longer possible and nutrition has to be delivered another way — a nasogastric or J-tube, or intravenous nutrition (TPN). These are the most serious cases in the stomach-injury litigation, and they are also the most thoroughly documented, because feeding-tube placement and TPN generate extensive hospital records at the time. Federal GLP-1 stomach cases are consolidated as MDL 3094, where 4,025 cases were pending as of October 2026.

Reports submitted to FDA are not verified and do not establish causation.

If you are reading this for someone you love

A lot of people who reach this page are not the patient. They are a husband, a wife, a daughter, a son — someone who has spent months watching this happen, learning to run a pump, counting calories that go in through a tube, and managing appointments for a person who is too tired to manage them.

You are in the right place, and you do not need their permission to find out what the options are. Nothing you do here commits them to anything. If they are not up to a phone call, you can make it. If you are holding a power of attorney, or if you are handling the affairs of someone who has died, there is a path for that too — just say so at the start and the conversation will be shaped around it.

What these cases look like

The path is usually long. It starts with vomiting and fullness that do not settle. There is weight loss that stops looking like a good thing and starts looking alarming. There is muscle wasting, weakness, a walker where there was not one before, dental damage from stomach acid, and repeated admissions for dehydration.

At some point a clinical team concludes that adequate nutrition cannot get in by mouth. That may mean a nasogastric tube as a temporary measure, a gastrostomy or jejunostomy tube for longer-term feeding, or total parenteral nutrition given intravenously when the gut cannot be used at all.

What families describe alongside the medical facts is the part no chart records: a person who cannot share a meal, who stays in their room, who misses the grandchildren’s events, and who says they do not know when they are going to get better — and that this is the hardest part.

The drug worked. That’s what makes this hard.

In many of these households the medication did what it was meant to do first. The weight came off. The diabetes numbers improved. Sometimes the whole reason for taking it was to be around longer and to be more present for the people in the house — and what happened next took that away instead.

There is no version of this where the reason for taking the medication makes the outcome deserved. You did what your doctor and the label told you was safe. Whatever the reason was, it isn’t what this is about. What matters is what patients and prescribers were told about the risks, and what they weren’t.

Why these cases are documented better than most

There is one small piece of good news on a page that has little of it. The hardest documentation problem in this litigation — proving the diagnosis with objective testing — is usually less of an obstacle at this level of severity.

On August 15, 2025, the court overseeing MDL 3094 ruled that any plaintiff claiming gastroparesis must show the diagnosis was based on a properly performed gastric emptying study. Most people told they have gastroparesis never had that test. But patients who deteriorate to tube feeding or TPN have typically been through motility workups, gastroenterology referrals and inpatient evaluation, and the testing is frequently somewhere in the file even when the family does not know it by name. Here is what the test is and how to find out whether it was done.

If it was not done, that is still not a statement about whether the illness was real — it is a documentation gap created by how this condition is ordinarily diagnosed, and it is worth a conversation rather than an assumption.

Who may qualify today

• Brand-name Ozempic, Wegovy, or Rybelsus. Compounded or generic semaglutide, and Mounjaro, Zepbound or Trulicity, don’t fit today’s stomach-injury criteria — tell us anyway; criteria differ by track.
• Gastroparesis confirmed by a gastric emptying study, or gastric obstruction confirmed by other objective testing.
• Diagnosed while taking the medication, or within about 30 days of stopping, and before December 31, 2024.
• An emergency room visit or hospital admission connected to the injury — at this level of severity there are usually several.
• Age 75 or under at intake, and not already represented by another lawyer for this issue.
• Tell us about the severity markers specifically: feeding tube or TPN, repeated admissions, surgery, extended time unable to work, dental damage, and whether the person is still not back to normal after stopping. These facts change how a case is evaluated.
• If the person has died, there is a separate intake path involving the estate and a personal representative. Say so at the beginning and we will handle it from there.

You are not suing the doctors

These claims are against the companies that made and labeled the medication — Novo Nordisk and Eli Lilly. They are not claims against the gastroenterologist, the surgeon who placed the tube, the nutrition team, the prescriber, or the pharmacy. In practice the treating clinicians are the people whose records support a claim most strongly, and nothing about a claim puts them at risk.

Common questions

Related stomach-injury topics: bowel obstruction & ileus, constant vomiting & ER visits, the gastric emptying study, and stomach paralysis (gastroparesis).